Recently, the "Smart Healthcare, Generating the Future - Generative AI Reshaping Healthcare and Life Sciences Innovation Symposium" hosted by Huaxun Network and Amazon Web Services concluded successfully at Conrad Hotel Shanghai. During the event, Huaxun Network and AWS jointly launched the MIH (Medical Insight Hub) solution.

In recent years, the deep integration of artificial intelligence, cloud computing, and big data technologies has continuously driven digital transformation in the healthcare and life sciences industry. The explosive breakthrough of generative AI is creating strategic opportunities for the healthcare and life sciences sector to restructure R&D approaches and accelerate knowledge accumulation.

This symposium focused on the application and future development of generative AI in the Healthcare and Life Sciences (HCLS) field, showcasing Huaxun Network's deep expertise and forward-looking vision in intelligent R&D, scenario-based applications, and industry engineering implementation.

Gao Cunyong, Industry Director of Life Sciences and Healthcare at AWS, opened the conference, stating that AWS is driving digital transformation in the industry through generative AI. Their professional capabilities encompass the generative AI technology stack, customer support, industry teams, and solution assets, with the goal of providing comprehensive end-to-end professional solutions and services to industry clients alongside partners.

As a leading digital solution service provider, Huaxun Network collaborated with AWS, Intsig Information, and other partners to explore cutting-edge directions and practical pathways for generative AI empowerment in HCLS, helping industry enterprises accelerate toward innovation and breakthroughs.

At the conference, Ma Da, AI Director of Fosun Pharma Group, served as a keynote speaker, introducing Fosun Pharma's exploration and practice of using AI technology to drive drug R&D and management decisions. He particularly highlighted the intelligent medical content generation center jointly developed with Huaxun Network and AWS. This platform integrates multiple functions including medical writing assistants, helping researchers significantly improve efficiency in processing vast literature and clinical data. In common use cases, the platform achieved 85% efficiency improvement while substantially enhancing accuracy and efficiency in R&D processes, fully demonstrating Huaxun Network's capabilities in solution engineering implementation.

In the keynote presentation, Shi Yingcheng, Technical Manager of Huaxun Network's Cloud Intelligence Excellence Center, systematically elaborated on the company's cloud-based intelligent R&D practices and industry insights in the "AI + Biopharma" field. He noted that life sciences companies generally face multi-layered challenges in implementing AI technology, ranging from business process restructuring, scenario planning, and model optimization to system integration development and full-cycle operational management.

Addressing these pain points, Huaxun Network leverages its deep industry expertise to provide AI solutions covering the entire drug development lifecycle:

In the R&D phase, through intelligent computing resource scheduling and management platforms, it efficiently coordinates and allocates computational resources, supporting computation-intensive tasks such as high-throughput screening and molecular simulation, significantly improving R&D efficiency.

In the clinical phase, utilizing natural language processing and large model technologies, it builds CSR (Clinical Study Report) consistency verification and assisted writing systems, improving document quality and compliance while reducing manual verification burden.

In the compliance phase, based on knowledge graphs and Retrieval-Augmented Generation (RAG) technology, it constructs GxP knowledge base management platforms, enabling intelligent retrieval and interpretation of regulations, Standard Operating Procedures (SOPs), and other documents.

With extensive project experience, Huaxun Network is committed to providing one-stop services from business consulting to engineering implementation for biopharmaceutical companies, helping enterprises transform AI proof-of-concepts into scalable applications and accelerate the efficient conversion of scientific research achievements into industrial value.

During the conference, Huaxun Network and AWS jointly released the MIH (Medical Insight Hub) solution. This solution not only provides production-level capabilities including Landing Zone configuration, large model switching, identity provider integration and access control, application monitoring and log alerts, cost management and throttling, but also offers innovative business scenario functions such as translation interface comparison editors, PDF translation format fine-tuning, multi-collaborative translation review workflows, intelligent terminology extraction, and customized enterprise knowledge bases. This solution highlights Huaxun Network's strong capability to deeply integrate AI technology with industry needs and create scalable, replicable solutions.

In the practical session, AWS technical experts demonstrated the latest Agentic AI applications based on the MDI (Medical Deep Insight) solution, vividly showing how it empowers medical writing and more life sciences application scenarios, earning high attention and recognition from attendees.

This symposium was not only an intellectual collision between academia and industry but also another important practice by Huaxun Network in promoting industry intelligent upgrades. In the future, Huaxun Network will continue to deeply cultivate the healthcare and life sciences vertical field, leveraging its leading technological capabilities and rich industry experience to work with partners in exploring the unlimited potential of generative AI, helping life sciences companies achieve higher-quality development.